Perimenopause is the new buzzword in the business of women’s health
Sarah Todd, STAT News
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Similasan Eye Relief products
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Settled
(Final approval granted)
https://www.homeopathiceyedropsettlement.com/home
Sarah Todd, STAT News
TINA.org finds more of the same – and then some – from retail giant.
FTC lawsuit alleged company duped consumers into signing up and then made it hard to cancel.
Your best defense against deceptive AI? A little research.
The surprising way you may be paying more for delivery.